| Dosages
(mg/kg/d) |
Body weight
(g) |
Ventral prostate
(mg/100g) |
Seminal Vesicle
(mg/100g) |
BC/LA
(mg/100g) |
Glans penis
(mg/100g) |
Cowper’s gland
(mg/100g) |
| 0 |
299 |
± |
18 |
7.3 |
± |
0.8 |
14.4 |
± |
4.2 |
65.2 |
± |
13.5 |
18.7 |
± |
3.4 |
2.6 |
± |
0.4 |
| 60 |
305 |
± |
22 |
8.6 |
± |
0.9* |
12.9 |
± |
1.8 |
60.1 |
± |
1.7 |
18.5 |
± |
1.6 |
2.2 |
± |
0.3 |
| 200 |
307 |
± |
15 |
9.6 |
± |
1.7* |
14.2 |
± |
1.4 |
59.9 |
± |
5.2 |
19.7 |
± |
2.5 |
2.8 |
± |
0.7 |
| 600 |
283 |
± |
20 |
8.4 |
± |
1.2 |
17.2 |
± |
1.8 |
56.7 |
± |
9.2 |
20.8 |
± |
2.0 |
2.8 |
± |
1.0 |
| TP |
337 |
± |
21 |
48.7 |
± |
5.8 |
130.9 |
± |
11.2 |
155.2 |
± |
10.6 |
28.5 |
± |
2.8 |
9.3 |
± |
0.7 |
| 60+TP |
341 |
± |
21 |
45.9 |
± |
6.6 |
140.1 |
± |
27.2 |
157.2 |
± |
14.2 |
29.0 |
± |
1.3 |
10.1 |
± |
2.3 |
| 200+TP |
332 |
± |
21 |
47.9 |
± |
7.3 |
144.0 |
± |
23.0 |
179.0 |
± |
12.8## |
30.1 |
± |
1.5 |
10.4 |
± |
2.4 |
| 600+TP |
313 |
± |
19 |
43.8 |
± |
7.7 |
141.8 |
± |
17.0 |
159.2 |
± |
24.1 |
29.8 |
± |
3.2 |
11.7 |
± |
2.0 |
| FT + TP |
329 |
± |
24 |
8.4 |
± |
1.3## |
15.0 |
± |
2.3## |
63.2 |
± |
7.8## |
18.6 |
± |
3.8## |
3.0 |
± |
0.7## |
TP; testosterone propionate, FT; flutamide, BC/LA; Bulbocavernosus and levator ani muscles.
* Significantly different from control at P<0.05.
## Significantly different from TP at P<0.01. |
